238 related articles for article (PubMed ID: 38128565)
1. Transarterial Radioembolization for Management of Hepatocellular Carcinoma.
Badar W; Yu Q; Patel M; Ahmed O
Oncologist; 2024 Feb; 29(2):117-122. PubMed ID: 38128565
[TBL] [Abstract][Full Text] [Related]
2. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization.
Lewandowski RJ; Kulik LM; Riaz A; Senthilnathan S; Mulcahy MF; Ryu RK; Ibrahim SM; Sato KT; Baker T; Miller FH; Omary R; Abecassis M; Salem R
Am J Transplant; 2009 Aug; 9(8):1920-8. PubMed ID: 19552767
[TBL] [Abstract][Full Text] [Related]
3. Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist.
Toskich BB; Liu DM
Tech Vasc Interv Radiol; 2019 Jun; 22(2):100-111. PubMed ID: 31079706
[TBL] [Abstract][Full Text] [Related]
4. Radiation Segmentectomy and Radiation Lobectomy: A Practical Review of Techniques.
Malhotra A; Liu DM; Talenfeld AD
Tech Vasc Interv Radiol; 2019 Jun; 22(2):49-57. PubMed ID: 31079710
[TBL] [Abstract][Full Text] [Related]
5. Contemporary applications of Y90 for the treatment of hepatocellular carcinoma.
Yu Q; Khanjyan M; Fidelman N; Pillai A
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37782464
[TBL] [Abstract][Full Text] [Related]
6. Evolution of Personalized Dosimetry for Radioembolization of Hepatocellular Carcinoma.
Knight GM; Gordon AC; Gates V; Talwar A; Riaz A; Salem R; Lewandowski R
J Vasc Interv Radiol; 2023 Jul; 34(7):1214-1225. PubMed ID: 36977431
[TBL] [Abstract][Full Text] [Related]
7. The Role of Radioembolization in Bridging and Downstaging Hepatocellular Carcinoma to Curative Therapy.
Titano J; Voutsinas N; Kim E
Semin Nucl Med; 2019 May; 49(3):189-196. PubMed ID: 30954184
[TBL] [Abstract][Full Text] [Related]
8. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
Kallini JR; Gabr A; Salem R; Lewandowski RJ
Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
[TBL] [Abstract][Full Text] [Related]
9. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.
Wehrenberg-Klee E; Gandhi RT; Ganguli S
Tech Vasc Interv Radiol; 2019 Jun; 22(2):70-73. PubMed ID: 31079713
[TBL] [Abstract][Full Text] [Related]
10. Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
Hickey RM; Lewandowski RJ; Salem R
Semin Nucl Med; 2016 Mar; 46(2):105-8. PubMed ID: 26897714
[TBL] [Abstract][Full Text] [Related]
11. Yttrium-90 for colorectal liver metastasis - the promising role of radiation segmentectomy as an alternative local cure.
Entezari P; Gabr A; Salem R; Lewandowski RJ
Int J Hyperthermia; 2022; 39(1):620-626. PubMed ID: 35465813
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma.
Gabr A; Abouchaleh N; Ali R; Baker T; Caicedo J; Katariya N; Abecassis M; Riaz A; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2018 Nov; 29(11):1502-1510.e1. PubMed ID: 30268638
[TBL] [Abstract][Full Text] [Related]
13. Transarterial Radioembolization Treatment as a Bridge to Surgical Resection in Pediatric Hepatocellular Carcinoma.
Whitlock RS; Loo C; Patel K; Bista R; Goss JA; Heczey A; Khan O; Lopez-Terrada D; Masand P; Nguyen H; Mahvash A; Vasudevan SA; Kukreja K
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1181-e1185. PubMed ID: 33769387
[TBL] [Abstract][Full Text] [Related]
14. Resin Versus Glass Microspheres for
Van Der Gucht A; Jreige M; Denys A; Blanc-Durand P; Boubaker A; Pomoni A; Mitsakis P; Silva-Monteiro M; Gnesin S; Lalonde MN; Duran R; Prior JO; Schaefer N
J Nucl Med; 2017 Aug; 58(8):1334-1340. PubMed ID: 28082436
[TBL] [Abstract][Full Text] [Related]
15. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
[TBL] [Abstract][Full Text] [Related]
16. Long-term Clinical Outcomes of Yttrium-90 Transarterial Radioembolization for Hepatocellular Carcinoma: A 5-Year Institutional Experience.
Makary MS; Bozer J; Miller ED; Diaz DA; Rikabi A
Acad Radiol; 2024 May; 31(5):1828-1835. PubMed ID: 37537129
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
Minocha J; Salem R; Lewandowski RJ
Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization.
Zhao K; Son S; Karimi A; Marinelli B; Erinjeri JP; Alexander ES; Sotirchos VS; Harding JJ; Soares KC; Ziv E; Covey A; Sofocleous CT; Yarmohammadi H
Curr Oncol; 2024 May; 31(5):2650-2661. PubMed ID: 38785481
[TBL] [Abstract][Full Text] [Related]
19. Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma.
Alem Z; Murray TE; Egri C; Chung J; Liu D; Elsayes KM; Chang SD; Harris A
Abdom Radiol (NY); 2021 Aug; 46(8):3596-3614. PubMed ID: 33909092
[TBL] [Abstract][Full Text] [Related]
20. Histological changes in nontumoral liver secondary to radioembolization of hepatocellular carcinoma with yttrium 90-impregnated microspheres: report of two cases.
Dhingra S; Schwartz M; Kim E; Mabel Ko H; Ward SC; Fiel MI; Thung SN
Semin Liver Dis; 2014 Nov; 34(4):465-8. PubMed ID: 25369308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
